You can buy or sell BioPharmX and other stocks, options, ETFs, and crypto commission-free!
BioPharmX Corp. engages in the provision of healthcare products through platform technologies for pharmaceutical, over-the-counter, and supplement applications in dermatology. Its platforms include Topical Gel, Injectable, and Encapsulation. Read More The company was founded by James R. Pekarsky and Anja B. Krammer on August 30, 2010 and is headquartered in Menlo Park, CA.
San Jose, California
52 Week High
52 Week Low
PR NewswireMar 21
BioPharmX Announces $3.9 Million Offering
SAN JOSE, Calif., March 21, 2019 /PRNewswire/ -- BioPharmX Corporation (NYSE American: BPMX), a specialty pharmaceutical company focused on developing innovative medical dermatology products, today announced that it has entered into securities purchase agreements with certain institutional investors for the purchase and sale of 43,645,000 shares of common stock at a price of $0.09 per share in a registered direct offering. The gross proceeds of the offering are expected to be approximately $3.9 million. Ne...
Markets InsiderMar 18
BioPharmX to Participate in the 31st Annual ROTH Conference and the Oppenheimer 29th Annual Healthcare Conference
SAN JOSE, Calif., March 18, 2019 /PRNewswire/ -- BioPharmX Corporation (NYSE American: BPMX), a specialty pharmaceutical company focused on developing innovative medical dermatology products, today announced presentations at multiple upcoming investor conferences. President and CEO Dr. David S. Tierney will present the latest company overview at: The 31 st Annual ROTH Conference on Monday, March 18 at 8:30am Pacific Time in Laguna Niguel, CA. Annual ROTH Conference on at in The Oppenheimer 29th Annual He...
-$0.01 per share